Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORAGENICS INC Director's Dealing 2018

Jul 17, 2018

35380_dirs_2018-07-17_a8dc4c1d-a283-4059-93e9-d27bc8285442.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2018-07-17

Reporting Person: Telling Fred (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-07-17 Common Stock P 100000 Acquired 239538 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-07-17 Common Stock Warrants (right to buy) $1.00 P 100000 Acquired 2025-07-17 Common Stock (100000) Direct

Footnotes

F1: Purchase of Class A Units consisting of one share of common stock and one warrant to purchase one share of common stock in an underwritten public offering at the price of $1.00 per Unit, which was the price paid by the public for such Units.